Mankind Pharma to lead Indian women's health market after BSV deal

Q: How long will it take to read this news story?

The story "Mankind Pharma to lead Indian women&#039;s health market after BSV deal" has 861 words across 9 sentences, which will take approximately 4 - 8 minutes for the average person to read.

Q: Which news outlet covered this story?

The story "Mankind Pharma to lead Indian women&#039;s health market after BSV deal" was covered 23 hours ago by Business Standard, a news publisher based in India.

Q: How trustworthy is 'Business Standard' news outlet?

Business Standard is a fully independent (privately-owned) news outlet established in 1975 that covers mostly business and finance news. The outlet is headquartered in India and publishes an average of 145 news stories per day. It's most recent story was published 2 hours ago.

Q: What do people currently think of this news story?

The sentiment for this story is currently Neutral, indicating that people are not responding positively or negatively to this news.

Q: How do I report this news for inaccuracy?

You can report an inaccurate news publication to us via our contact page. Please also include the news #ID number and the URL to this story.<ul><li>News ID: #21785074</li><li>URL: https://beamstart.com/news/mankind-pharma-to-lead-indian-17220057188276</li></ul>

Business Standard Logo Business Standard 23h ago

Mankind Pharma to lead Indian women's health market after BSV deal - Business Standard

Quick Summary:

Mankind said the domestic product portfolio has huge scalability potential through niche filings across markets.“Amid increasing IVF penetration, this offers growth potential.

The deal is expected to be closed in three to four months and will be funded through internal accruals and a mix of debt and equity.“Around Rs 4,000 crore will be raised through internal accruals, the balance will be raised via debt,” Juneja said in an analyst call on Friday.

BSV is a leading branded speciality pharma platform in women’s health and critical care with huge opportunities in both India and international markets.